GUILFORD, Conn., March 24, 2018 -- Butterfly Network Inc. announced today that it has developed a novel augmented reality telemedicine technology on Butterly iQ™, the world’s first whole-body ultrasound imager. Butterfly iQ is a personal ultrasound device and sells for less than $2,000. Using Butterfly Tele-Guidance™ technology, an ultrasound expert can remotely guide any user to acquire even the most challenging ultrasound scans, bringing medical expertise to wherever it’s needed most. Only a fraction of the 40 million healthcare workers worldwide have the expertise to capture and interpret ultrasound images. Butterfly Tele-Guidance will expand their reach and facilitate early diagnosis and preventive medicine.
“This is an important step in fulfilling the promise of bringing ultrasound to the millions that do not have access to this essential medical technology,” said founder and serial entrepreneur Dr. Jonathan M. Rothberg. “I set out to democratize ultrasound imaging as I did with DNA sequencing. Two-thirds of the world has no access to medical imaging, and even in the developed world, expense and lack of expertise limit its accessibility. We solved the expense hurdle with the Butterfly iQ, and now with Butterfly Tele-Guidance technology, we are providing a unique approach to solving the expertise shortage.”
Butterfly Network conquered the problem of affordability of ultrasound systems by leveraging semiconductor technology and replacing the piezoelectric crystals with the world’s first commercial Ultrasound-on-a Chip™. Butterfly iQ received FDA clearance for 13 indications, the broadest ever for a single ultrasound probe, making it the only whole-body ultrasound imager. Priced at under $2k, the iQ also is the first personal ultrasound device, paving the way for all healthcare professionals to have a window into the body.
Butterfly Tele-Guidance is currently available for investigational and educational use only. Learn more at www.butterflynetwork.com.
ABOUT
Butterfly Network is a health technology company dedicated to democratizing medical imaging. Using a full-stack engineering approach combining hardware and software, Butterfly introduces the era of personal ultrasound with iQTM, the world’s first whole-body ultrasound system. Uniting a unique Transducer-on-CMOS technology with AI and the cloud, Butterfly iQ brings consumer-level ease of use and affordable imaging to the millions of healthcare practitioners without access. Butterfly Network invented and introduced the first FDA-cleared personal ultrasound device using ultrasound-on-a-chip™ technology. Butterfly has offices in NYC, Palo Alto and Guilford, Connecticut and is a member of the 4Catalyzer life sciences incubator, founded by Dr. Jonathan M. Rothberg, best known for inventing next-generation DNA sequencing, the technology underlying the $1,000 genome and the precision medical revolution.
CONTACT:
Wes Conard
[email protected]
415 385-4455
https://www.butterflynetwork.com/


Trump Urges Exxon, Chevron to Cut Gas Prices After Record Oil Profits
Shein Targets $30B-$40B Valuation in Hong Kong IPO Planned for August
SK Hynix Bonus Dispute Deepens as Union Rejects Stock-Based Payout Proposal
BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges
Roblox Stock Drops 16% as Q3 Bookings Forecast Misses Expectations
Telegram Restored on Apple App Store After Temporary Removal
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat
Apple Restores Telegram to App Store After Content Policy Violation
BHP Port Hedland Strike Set to Proceed as Wage Talks Continue
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion
Vast Eyes Hong Kong IPO as Chinese AI Unicorn Gains Momentum
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight
HSBC H1 Profit Jumps 23%, Announces $1 Billion Share Buyback and Reaffirms 2028 Targets
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand 



